Historical record - last NADAC publication: 8/23/2023
Product Information
PIOGLITAZONE HCL 45 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1370 per EA under NDC 43547042803. Its NADAC has been published 235 times since Feb 27, 2019.
The High Outlier badge above means this manufacturer's average price in the Pioglitazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
45 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547042803
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
8/23/2023
Active Ingredients
PIOGLITAZONEApproval Type
Generic (ANDA)
FDA Application
ANDA207806On Market Since
5/20/2018
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 45 MG TABLET has been published 235 times since Feb 27, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1370 per EA |
|---|---|
| All-time high | $0.1794 (Jan 13, 2021) |
| All-time low | $0.1281 (Aug 21, 2019) |
| Median price | $0.1457 |
| Average price | $0.1506 |
| Largest weekly change | +13.5% (Jun 17, 2020) |
| Weeks tracked | 235 |
| Tracking since | Feb 27, 2019 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 45 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 45 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1370 per EA (NDC 43547042803), effective Aug 23, 2023.
How has the price of PIOGLITAZONE HCL 45 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has held within roughly two percent of its current level. It has been tracked across 235 weekly CMS publications since Feb 27, 2019.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 45 MG TABLET?
Since Feb 27, 2019, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has ranged from a low of $0.1281 (Aug 21, 2019) to a high of $0.1794 (Jan 13, 2021), with a median of $0.1457 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 45 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PIOGLITAZONE HCL 45 MG TABLET, is $0.1144 per EA — about 16% below PIOGLITAZONE HCL 45 MG TABLET.
Who manufactures PIOGLITAZONE HCL 45 MG TABLET?
PIOGLITAZONE HCL 45 MG TABLET (NDC 43547042803) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification